Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.
As European markets rally following the U.S.-Iran ceasefire agreement, investor sentiment has improved, leading to notable gains across major indices such as Germany's DAX and France's CAC 40. In this environment of cautious optimism, identifying stocks that may be trading below their estimated value can offer opportunities for investors who are mindful of economic forecasts and geopolitical risks.
What the mixed earnings signal for Veralto (VLTO) investors
Veralto (VLTO) recently reported quarterly results that combined revenue growth with an earnings beat, while guidance for the next quarter's earnings per share came in below market expectations.
This mix of current performance and cautious outlook has drawn attention to how the stock might reflect investor views on water quality, emissions monitoring, and broader demand for the company's analytics and treatment solutions.
See our...
As European markets continue to react positively to geopolitical developments, with the STOXX Europe 600 Index gaining over 3% recently, investors are exploring diverse opportunities within the region. Penny stocks, while an older term, still represent a vital segment of the market by highlighting smaller or emerging companies that can offer substantial value. By focusing on those with strong financials and growth potential, investors may uncover promising opportunities among these...
a2 Milk (NZSE:ATM) cut its revenue and profit outlook after supply chain problems, including Synlait production issues, shipment delays linked to the Iran conflict, global recalls, and higher freight costs, disrupted infant formula availability in China.
See our latest analysis for a2 Milk.
The supply chain guidance cut and the recent class action settlement news have coincided with clear selling pressure, with a2 Milk’s share price down 18.7% over 7 days and 19.7% over 30 days, even though...
Roche has launched a new global Phase 3 trial of Elevidys, Sarepta Therapeutics’ gene therapy for Duchenne muscular dystrophy, enrolling about 100 early ambulatory patients over a 72‑week period to generate additional data for a revised European approval bid.
This renewed clinical push underscores Roche’s continued commitment to Elevidys and highlights the potential for broader geographic access beyond the United States despite earlier European regulatory setbacks.
We’ll now examine how...
As European markets rally amid improving global sentiment following a U.S.-Iran ceasefire, investors are increasingly looking towards smaller, lesser-known companies that may offer unique opportunities. In this context, identifying stocks with solid fundamentals and potential for growth can be particularly rewarding as market conditions evolve.
As European markets rally, with the pan-European STOXX Europe 600 Index climbing over 3% amid easing geopolitical tensions and a temporary ceasefire between the U.S. and Iran, investors are keenly observing how these dynamics might influence economic growth forecasts and inflationary pressures. In this context, dividend stocks offer a potentially attractive option for those seeking income stability in uncertain times, as they can provide regular returns even when market volatility is high.
In recent years, RLI, a specialty insurer founded in 1965, has grown its market share, with annual revenue and net premiums earned each rising more than 13% on average over the last five years. This expansion, alongside a return on equity of 27.9%, points to highly effective underwriting and capital allocation across its property, casualty, and surety lines.
We’ll now explore how RLI’s sustained double‑digit revenue and premium growth, underpinned by a high return on equity, may reshape its...
Goosehead Insurance (GSHD) has drawn investor attention after recent share price swings, including a roughly 5% move over the past day, set against a backdrop of weaker returns over the past year and past 3 months.
See our latest analysis for Goosehead Insurance.
That 4.98% 1 day share price return and 2.37% 7 day share price return come against a 30 day share price decline of 3.95% and a much steeper 1 year total shareholder return loss of 59.60%. This suggests that recent momentum is still...
What the Electra partnership means for Edenred (ENXTPA:EDEN)
Edenred (ENXTPA:EDEN) has agreed with Electra to offer a 30% discount on ultra-fast EV charging for Edenred Mobilité corporate customers in France, fully integrated into its existing all-in-one platform.
The move directly targets cost and accessibility barriers for companies running or considering electric fleets. It also gives investors another data point on how Edenred is positioning its mobility segment within its broader digital...
Wondering if Palomar Holdings at around US$131 per share still offers value, or if most of the opportunity is already priced in.
The stock has slipped 1.7% over the last week, but is up 10.4% over 30 days, while the year-to-date return is roughly flat at a 0.3% decline and the 1-year return sits at a 12.3% decline. Taken together, this gives a mixed picture for recent performance.
Recent headlines around Palomar have focused on its position within the wider insurance sector and how investors...
In early April 2026, Precigen Inc. reiterated that first-quarter sales of its lead respiratory treatment, PAPZIMEOS, are expected to exceed US$18,000,000, shortly after the Centers for Medicare & Medicaid Services granted the drug a permanent J-code (J3404) to streamline reimbursement and broaden patient access.
This combination of a clearer reimbursement pathway and management’s confidence in PAPZIMEOS demand highlights how payer recognition can reinforce the company’s commercialization...
On April 6, 2026, HealthEquity, Inc. disclosed that it terminated Chief Technology Officer Eli Rosner’s employment without cause, effective April 17, 2026, and assigned Executive Vice President, Chief Product and Strategy Officer Sunil Rajasekar to oversee the technology organization.
This shift places HealthEquity’s core technology, product, and strategy responsibilities under a single executive with extensive experience leading digital platforms at Billtrust, MINDBODY, eBay, Intuit, and...
As global markets respond to easing geopolitical tensions and investors shift back into riskier assets, the Asian stock market presents intriguing opportunities for those seeking value. In this environment, identifying stocks that are trading below their intrinsic value can be particularly appealing, as they may offer potential for growth when market sentiment improves.
Amid a backdrop of improving market sentiment driven by geopolitical developments and optimism in technology sectors, Asian markets have shown resilience and potential for growth. For investors looking beyond the established giants, penny stocks—though an older term—remain a relevant area of interest due to their affordability and potential for substantial returns. This article explores three promising Asian penny stocks that stand out for their financial strength and growth prospects,...
As global markets rally on improved sentiment following a U.S.-Iran ceasefire, investors are increasingly turning their attention to the dynamic and often underexplored Asian markets. In this environment, identifying promising stocks involves looking for companies with strong fundamentals and growth potential that can thrive amid geopolitical shifts and economic changes.
If you are wondering whether Extra Space Storage is attractively priced or already fully valued, starting with a clear view of what you are paying for each future dollar of cash flow can help frame the decision.
The share price recently closed at US$141.64, with returns of 1.7% over 7 days, 2.4% over 30 days, 8.1% year to date, 5.0% over 1 year, 6.3% over 3 years and 17.1% over 5 years. These figures can reshape how investors think about both potential and risk.
Recent headlines around Extra...
